期刊
ADDICTION BIOLOGY
卷 25, 期 4, 页码 -出版社
WILEY
DOI: 10.1111/adb.12783
关键词
cannabidiol; cannabinoid; CB1 receptor; CB2 receptor; feeding behavior; sucrose self-administration
资金
- NATIONAL INSTITUTE ON DRUG ABUSE [ZIGDA000633] Funding Source: NIH RePORTER
- Intramural NIH HHS [Z99 DA999999] Funding Source: Medline
- NIDA NIH HHS [DA000620-02] Funding Source: Medline
A growing number of studies suggest therapeutic applications of cannabidiol (CBD), a recently U.S. Food and Drug Administration (FDA)-approved medication for epilepsy, in treatment of many other neuropsychological disorders. However, pharmacological action and the mechanisms by which CBD exerts its effects are not fully understood. Here, we examined the effects of CBD on oral sucrose self-administration in rodents and explored the receptor mechanisms underlying CBD-induced behavioral effects using pharmacological and transgenic approaches. Systemic administration of CBD (10, 20, and 40 mg/kg, ip) produced a dose-dependent reduction in sucrose self-administration in rats and in wild-type (WT) and CB1(-/-) mice but not in CB2(-/-) mice. CBD appeared to be more efficacious in CB1(-/-) mice than in WT mice. Similarly, pretreatment with AM251, a CB1R antagonist, potentiated, while AM630, a selective CB2R antagonist, blocked CBD-induced reduction in sucrose self-administration, suggesting the involvement of CB1 and CB2 receptors. Furthermore, systemic administration of JWH133, a selective CB2R agonist, also produced a dose-dependent reduction in sucrose self-administration in WT and CB1(-/-) mice, but not in CB2(-/-) mice. Pretreatment with AM251 enhanced, while AM630 blocked JWH133-induced reduction in sucrose self-administration in WT mice, suggesting that CBD inhibits sucrose self-administration likely by CB1 receptor antagonism and CB2 receptor agonism. Taken together, the present findings suggest that CBD may have therapeutic potential in reducing binge eating and the development of obesity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据